|
WO2011123236A1
|
|
D-tagatose and biguanide compositions and methods
|
|
US6355409B1
|
|
Tagatose as a cytoprotective supplement for the removal and/or storage of organs to reduce reperfusion injury
|
|
WO0068369A1
|
|
Method for preventing or minimizing biodegradation of a substance
|
|
US6585964B1
|
|
Method for preventing or minimizing biodegradation of a substance
|
|
US6015793A
|
|
Use of tagatose to enhance key blood factors
|
|
US6225452B1
|
|
Increased fertility and improved fetal development drug
|
|
US5690950A
|
|
Insecticidal aliphatic carboxylic acid compositons
|
|
US5217537A
|
|
Crystalline form of L-gulose
|
|
US5215591A
|
|
Crystalline form of D-gulose
|
|
US5356879A
|
|
D-tagatose as anti-hyperglycemic agent
|
|
CA2077257A1
|
|
Process for manufacturing tagatose
|
|
US4956094A
|
|
Enhanced phosphate removal from bod-containing wastewater
|
|
US5002612A
|
|
Process for manufacturing tagatose
|
|
US5166193A
|
|
Method for killing pests
|
|
US4786722A
|
|
D-tagatose as a low-calorie carbohydrate sweetener and bulking agent
|
|
DE3414382A1
|
|
Use of L-sugar
|
|
JPS57129671A
|
|
Sweetened edible compound
|
|
CA1150999A
|
|
Sweetened edible formulations
|
|
US4294931A
|
|
Device for conducting microbiological radiorespirometric assays
|
|
US4200524A
|
|
Bio-surface separation process
|
